1.Long-term and stable correction of uremic anemia by intramuscular injection of plasmids containing hypoxia-regulated system of erythropoietin expression.
Jifeng SUN ; Yarong WANG ; Jie YANG ; Dewei DU ; Zhanting LI ; Junxia WEI ; Angang YANG
Experimental & Molecular Medicine 2012;44(11):674-683
Relative deficiency in production of glycoprotein hormone erythropoietin (Epo) is a major cause of renal anemia. This study planned to investigate whether the hypoxia-regulated system of Epo expression, constructed by fusing Epo gene to the chimeric phosphoglycerate kinase (PGK) hypoxia response elements (HRE) in combination with cytomegalovirus immediate-early (CMV IE) basal gene promoter and delivered by plasmid intramuscular injection, might provide a long-term physiologically regulated Epo secretion expression to correct the anemia in adenine-induced uremic rats. Plasmid vectors (pHRE-Epo) were synthesized by fusing human Epo cDNA to the HRE/CMV promoter. Hypoxia-inducible activity of this promoter was evaluated first in vitro and then in vivo in healthy and uremic rats (n = 30 per group). The vectors (pCMV-Epo) in which Epo expression was directed by a constitutive CMV gene promoter served as control. ANOVA and Student's t-test were used to analyze between-group differences. A high-level expression of Epo was induced by hypoxia in vitro and in vivo. Though both pHRE-Epo and pCMV-Epo corrected anemia, the hematocrit of the pCMV-Epo-treated rats exceeded the normal (P < 0.05), but that of the pHRE-Epo-treated rats didn't. Hypoxia-regulated system of Epo gene expression constructed by fusing Epo to the HRE/CMV promoter and delivered by plasmid intramuscular injection may provide a long-term and stable Epo expression and secretion in vivo to correct the anemia in adenine-induced uremic rats.
Anemia/blood/*therapy
;
Animals
;
Base Sequence
;
Blood Urea Nitrogen
;
Cell Hypoxia
;
Creatinine/blood
;
Erythropoietin/biosynthesis/*genetics/secretion
;
Gene Expression Regulation
;
Genes, Reporter
;
Genetic Therapy
;
HeLa Cells
;
Humans
;
Injections, Intramuscular
;
Kidney/pathology
;
Luciferases, Firefly/biosynthesis/genetics
;
Molecular Sequence Data
;
Plasmids/*genetics
;
Promoter Regions, Genetic
;
Rats
;
Rats, Sprague-Dawley
;
Recombinant Proteins/biosynthesis/genetics/secretion
;
Response Elements
;
Transcriptional Activation
;
Uremia/blood/*therapy